Pharmaceuticals

Global Colorectal Cancer Drugs Market 2015-2019

  • TEC250645
  • 125 Pages
  • June 2015
  • Pharmaceuticals
About Colorectal Cancer

Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Colorectal cancer is the third most common cancer in the US. Some of the risk factors that can cause colorectal cancer are lifestyle changes, old age, genetic disorders, family history, and inflammatory bowel disease. Some of the symptoms of colorectal cancer are blood in stool, decrease in appetite, constipation, weight loss, nausea, bloating, and pelvic pain. Colorectal cancer can be classified into four broad stages. Colorectal cancer can be treated using surgical, chemotherapeutic, biologic, and radiation therapies.

Technavio's analysts forecast the global colorectal cancer drugs market to grow at a CAGR of 3.62% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global colorectal cancer drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from sales of various drugs used in the treatment of colorectal cancer.

Based on the type of molecule, the market is grouped into two categories:

Biologics
Small molecules

Based on the route of administration, the market is grouped into two categories:

Oral
Parenteral

This report covers the present scenario and the growth prospects of the global colorectal cancer drugs market for the period 2015-2019 in the following regions:

Americas: The principal countries focused upon in this region are the US, Canada, Mexico, and Brazil
EMEA: The principal countries focused upon in this region are the UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and UAE. Germany, Italy, and the UK are the leading European countries in terms of elderly population

APAC: The principal countries focused upon in this region are Japan, China, Australia, Singapore, South Korea, and India.

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors as well as the competitive performances of their product portfolios in the market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market.

Technavio's report, Global Colorectal Cancer Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the global colorectal cancer drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions
Americas
APAC
EMEA

Key Vendors
Amgen
Bayer
Bristol-Myers Squibb
F. Hoffmann-La Roche
Merck Serono

Other Prominent Vendors
Accord Healthcare
Advenchen Laboratories
Aeterna Zentaris
AstraZeneca
Bavarian Nordic
Biothera
Boehringer Ingelheim
Daiichi Sankyo
Debiopharm
Eisai
Eli Lilly
Immodulon Therapeutics
Mologen
Mylan
Nektar Therapeutics
Oncothyreon
Otsuka Pharmaceutical
Precision Biologics
Sun Pharmaceutical
Symphogen
Taiho
Takeda
Teva
ThromboGenics
Xbiotech
Yakult Honsha

Market Driver
Increase in population of patients
For a full, detailed list, view our report

Market Challenge
Loss of patent exclusivity
For a full, detailed list, view our report

Market Trend
Dominance of biologics
For a full, detailed list, view our report

Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Pharmaceutical Contract Manufacturing Market (Drug Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

The global market for pharmaceutical contract manufacturing represents one of the fastest growing markets and it is expected to proffer enormous opportunities in the near future. Contract manufacturing contributes significantly ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Therapeutic Vaccines Market (Product, Technology, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013-2020

Therapeutic vaccines are provided to the body during treatment of specific diseases. This vaccine triggers and strengthens the immune response of the body to act against a disease. In 2011, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Nanomedicine Asia-Pacific Market Research Report, 2014 - 2020

Nanomedicine is the applied branch of nanotechnology. Application of nanomedicines ranges from nonmaterial to nanoelectronic and in the near future, it could possibly expand to molecular nanotechnology. Biological, pharmaceutical and ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global Market for STDs Diagnosis (Type, Location and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Sexually transmitted diseases spread through sexual contact. The cause of these diseases may be bacterial, fungal, viral or protozoa infections. The major types of these diseases include Chlamydia, herpes, human ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Hemoglobinopathies Market (Pipeline Therapeutics and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules, particularly defective globin chains. Hemoglobinopathies are inherited single-gene disorders of which sickle cell disease is the most common ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Cryosurgery Asia-Pacific Market Research Report, 2013 - 2020

Cryosurgery or Cryotherapy is a minimally invasive treatment that subjects the use of extremely cold temperatures to freeze and destroy diseased tissues, largely used in the treatment of cancer. To ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

2017 © Copyright Big Market Research

View Pricing >>